|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| (11) | Number of the document | 1960430 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06820403.1 |
| Date of filing the European patent application | 2006-12-04 | |
| (97) | Date of publication of the European application | 2008-08-27 |
| (45) | Date of publication and mention of the grant of the patent | 2014-09-24 |
| (46) | Date of publication of the claims translation | 2015-01-25 |
| (86) | Number | PCT/GB2006/004518 |
| Date | 2006-12-04 |
| (87) | Number | WO 2007/066082 |
| Date | 2007-06-14 |
| (30) | Number | Date | Country code |
| 748926 P | 2005-12-09 | US |
| (72) |
GELINAS, Richard, Evan, GB
SINGHAL, Mitra, Choudhury, GB
ZHANG, Yi, GB
POPPLEWELL, Andrew, George, GB
ADAMS, Ralph, GB
|
| (73) |
R-PHARM INTERNATIONAL, LLC,
19, bld.1, Berzarina street, first floor, premise V, room 9, Moscow, 123154,
RU
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnų molekulės, pasižyminčios specifiškumu žmogaus IL-6 atžvilgiu |
| ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-6 |
| Payment date | Validity (years) | Amount | |
| 2025-11-26 | 20 | 347.00 EUR |